HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)

Completed · Phase 2 · Has a placebo group

Conditions studied: Age-Associated Memory Impairment (AAMI)

In brief

This is a Phase 2 randomized, multicenter, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy of HT-0712 in improving memory and cognitive performance in subjects with Age-Associated Memory Impairment (AAMI)

Key facts

Study ID

NCT02013310

Run by

Dart NeuroScience, LLC

People needed

119

Starts

2013-12-01

Expected to finish

2015-01-01

Last updated by the study team

2015-12-30

Who can join

Age: 50 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Sun City, Arizona, United States
• Study site — Long Beach, California, United States
• Study site — Santa Monica, California, United States
• Study site — Denver, Colorado, United States
• Study site — Atlantis, Florida, United States
• Study site — Brooksville, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Marlton, New Jersey, United States
• Study site — Princeton, New Jersey, United States
• Study site — New York, New York, United States
• Study site — Dayton, Ohio, United States
• Study site — Tulsa, Oklahoma, United States
• Study site — Cordova, Tennessee, United States
• Study site — Austin, Texas, United States
• Study site — San Antonio, Texas, United States
• Study site — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.